05/15/2026
"The Osteo Science Foundation 2026 Bone Symposium was an outstanding educational experience. Spanning fundamental science to clinical application, the program offered invaluable insights from world-renowned researchers and clinicians. Among the many excellent lectures, two talks in particular have stayed with me since.
Dr. Misch's presentation on horizontal and vertical bone augmentation was especially compelling. He surveyed a range of contemporary techniques while reframing the central clinical question, shifting the emphasis from how much bone remains to how much bone needs to be grown. His evidence-based algorithm for managing horizontal and vertical deficiencies has already begun to influence the way I evaluate and treatment-plan my patients on a daily basis.
The lecture on osteoporosis medications was equally valuable. I was introduced to Romosozumab, a newer anabolic agent that reduces fracture risk through a mechanism distinct from the anti-resorptive. Compared with the well-established literature on bisphosphonates such as zoledronic acid and the RANKL inhibitor denosumab, data on Romosozumab and its association with medication-related osteonecrosis of the jaw (MRONJ) remain relatively limited, a gap that, to me, represents a promising avenue for further investigation.
The cutting-edge science and clinical expertise shared by the faculty will undoubtedly shape my development throughout residency and my subsequent career as an oral and maxillofacial surgeon. Above all, though, nothing will top riding a bull in cowboy
boots and jeans."
Jaeyoung Choi, DDS
Osteo Science Foundation 2026 Bone Symposium Resident Travel Award Recipient